FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5629 | 26436-5629-1 | Naltrexone Hydrochloride Dihydrate | 2 mg | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 20 mg/1 g; 80 mg/1 g | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5066 | 26436-5066-3 | Niacinamide | 100 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-3 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5233 | 26436-5233-6 | Nystatin | 100000 U/1 g | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5233 | 26436-5233-3 | Nystatin | 100000 U/1 g | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5007 | 26436-5007-3 | Panthenol | 250 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5112 | 26436-5112-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 20 ug/1 mL; 2 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5097 | 26436-5097-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5580 | 26436-5580-1 | Phenol | 50 mg/1 mL | 2025-2 | valid | 2026-08-10 | |
| Hybrid Pharma | 079665742 | 26436-5601 | 26436-5601-5 | Phentolamine Mesylate; Papaverine Hydrochloride; Alprostadil | 4 mg/1 mL; 40 mg/1 mL; 30 ug/1 mL | 2025-2 | valid | 2026-08-10 | |
| Imprimis NJOF, LLC | 080431967 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Bimatoprost | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Prednisolone Acetate | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 5 mg/1 mL; .75 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 5 mg/1 mL; .75 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Proparacaine Hydrochloride; Povidone-Iodine | 5 mg/1 mL; 125 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Timolol Maleate; Bimatoprost | 5 mg/1 mL; .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine | 5 mg/1 mL; 20 mg/1 mL; 1.5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 5 mg/1 mL; 20 mg/1 mL; 1.5 mg/1 mL; .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Vancomycin Hydrochloride | 25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Vancomycin Hydrochloride; Tobramycin | 50 mg/1 mL; 15 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Vancomycin Hydrochloride; Tobramycin | 25 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Cyclosporine | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Dorzolamide Hydrochloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Dorzolamide Hydrochloride; Bimatoprost; Timolol Maleate | 20 mg/1 mL; .1 mg/1 mL; 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Dorzolamide Hydrochloride; Brimonidine | 20 mg/1 mL; 1.5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Atropine Sulfate | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Atropine Sulfate | .25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Atropine Sulfate | .5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 7.5 mg/1 mL; .25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Loteprednol Etabonate | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Azithromycin Dihydrate | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 5 mg/1 mL; .75 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 | |||
| Imprimis NJOF, LLC | 080431967 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-10 |